Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
diethylamino(benzylidine-amino)guanidine + NAD+
?
-
DEABAG
-
-
?
eEF2 + NAD+
eEF2 N-(ADP-D-ribosyl)diphthamide + NADH + H+
NAD+ + diphthamide-[Escherichia coli elongation factor Tu]
nicotinamide + N-(ADP-D-ribosyl)diphthamide-[Escherichia coli elongation factor Tu]
-
-
-
?
NAD+ + diphthamide-[translation elongation factor 2]
nicotinamide + N-(ADP-D-ribosyl)diphthamide-[translation elongation factor 2]
NAD+ + elongation factor 2
nicotinamide + ADPribose-elongation factor 2
NAD+ + essential ribosomal elongation factor 2
nicotinamide + H+ + ADP-ribosylated essential ribosomal elongation factor 2
NAD+ + G-protein
?
-
NAD-dependent ADP-ribosylation of Arg201 of G-protein alpha-subunit, this locks the G-protein in its active state producing cAMP
-
-
?
NAD+ + peptide diphthamide
nicotinamide + peptide N-(ADP-D-ribosyl)diphthamide
-
-
-
-
?
additional information
?
-
eEF2 + NAD+
eEF2 N-(ADP-D-ribosyl)diphthamide + NADH + H+
-
i.e. eukaryotic elongation factor 2, contains a post-translationally modified histidine residue, known as diphthamide, which is the specific ADP-ribosylation target of Pseudomonas aeruginosa exotoxin A
-
-
?
eEF2 + NAD+
eEF2 N-(ADP-D-ribosyl)diphthamide + NADH + H+
-
i.e. eukaryotic elongation factor 2 with a diphthamide-containing loop comprising residues Leu693-Gly703, ADP-ribosylation at His699, site determination by mass spectrometry and mutational analysis, overview
-
-
?
NAD+ + diphthamide-[translation elongation factor 2]
nicotinamide + N-(ADP-D-ribosyl)diphthamide-[translation elongation factor 2]
-
-
-
-
?
NAD+ + diphthamide-[translation elongation factor 2]
nicotinamide + N-(ADP-D-ribosyl)diphthamide-[translation elongation factor 2]
-
-
-
?
NAD+ + diphthamide-[translation elongation factor 2]
nicotinamide + N-(ADP-D-ribosyl)diphthamide-[translation elongation factor 2]
-
-
-
?
NAD+ + elongation factor 2
nicotinamide + ADPribose-elongation factor 2
-
liver enzyme
-
?
NAD+ + elongation factor 2
nicotinamide + ADPribose-elongation factor 2
-
i.e. elongation factor 2 of baby hamster kidney cells, forward ADP-ribosylation reaction is reversed by fragment A from Pseudomonas aeruginosa
-
r
NAD+ + elongation factor 2
nicotinamide + ADPribose-elongation factor 2
-
-
-
?
NAD+ + elongation factor 2
nicotinamide + ADPribose-elongation factor 2
-
-
-
r
NAD+ + elongation factor 2
nicotinamide + ADPribose-elongation factor 2
-
NAD-glycohydrolase activity without acceptor substrate
-
?
NAD+ + elongation factor 2
nicotinamide + ADPribose-elongation factor 2
-
reaction involves a random-order ternary complex
-
-
?
NAD+ + elongation factor 2
nicotinamide + ADPribose-elongation factor 2
-
-
-
-
?
NAD+ + essential ribosomal elongation factor 2
nicotinamide + H+ + ADP-ribosylated essential ribosomal elongation factor 2
transfer of ADP-ribose moiety (oxocarbenium ion) of NAD+ onto N3 of diphthamide imidazole of essential ribosomal elongation factor 2 (eEF2)
-
-
?
NAD+ + essential ribosomal elongation factor 2
nicotinamide + H+ + ADP-ribosylated essential ribosomal elongation factor 2
essential ribosomal elongation factor 2: eEF2, 2-step reaction by concerted GH and ADPRT activity, transition-state model
-
-
?
additional information
?
-
NAD+-dependent ADP-ribosyltransfer (ADPRT) including NAD+-glycohydrolysis (GH) activity, deadly virulent due to covalent modification and thus inactivation of proteins that are essential for the host
-
-
?
additional information
?
-
-
NAD+-dependent ADP-ribosyltransfer (ADPRT) including NAD+-glycohydrolysis (GH) activity, deadly virulent due to covalent modification and thus inactivation of proteins that are essential for the host
-
-
?
additional information
?
-
no ADP-ribosyl transfer by mutants R551H and R551C despite of occurring NAD+-binding and hydrolysis
-
-
?
additional information
?
-
-
no ADP-ribosyl transfer by mutants R551H and R551C despite of occurring NAD+-binding and hydrolysis
-
-
?
additional information
?
-
-
cholera toxin activates mouse bone marrow mast cells to release interleukin-4 via activation of nucleotide oligomerisation domain 1 and toll-like receptor-4, and initiation of antigen-specific T-helper 2 response
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
1,8-naphthalimide
-
potent competitive
1H-benzo[de]isoquinoline-1,3(2H)-dione
-
2-[(5,6-dimethyl-4-oxo-3,4,4a,7a-tetrahydrothieno[2,3-d]pyrimidin-2-yl)sulfanyl]-N-(2-hydroxyethyl)acetamide
-
3-((3,3-diethylguanidino)methyl)benzamide
-
1 mM, 37°C, pH 7, 24% inhibition
3-((3,3-diisopropylguanidino)methyl)benzamide
-
1 mM, 37°C, pH 7, 94% inhibition
3-((3-(1-benzylpiperidin-4-yl)guanidino)methyl)benzamide
-
1 mM, 37°C, pH 7, 96% inhibition
3-((3-(1-benzylpyrrolidin-3-yl)guanidino)methyl)benzamide
-
1 mM, 37°C, pH 7, 68% inhibition
3-((3-(2-(ethyl(m-tolyl)amino)ethyl)guanidino)methyl)benzamide
-
1 mM, 37°C, pH 7, 76% inhibition
3-((3-(2-morpholinoethyl)guanidino)methyl)benzamide
-
1 mM, 37°C, pH 7, 57% inhibition
3-((3-(4-bromobenzyl)guanidino)methyl)benzamide
-
1 mM, 37°C, pH 7, 98% inhibition
3-((3-(4-methoxybenzyl)guanidino)methyl)benzamide
-
1 mM, 37°C, pH 7, 97% inhibition, not sufficient material for IC50 and Ki estimation
3-((3-benzylguanidino)methyl)benzamide
-
1 mM, 37°C, pH 7, 93% inhibition
3-((3-phenethylguanidino)methyl)benzamide
-
1 mM, 37°C, pH 7, 93% inhibition
3-((3-phenylguanidino)methyl)benzamide
-
1 mM, 37°C, pH 7, 57% inhibition
3-((3-tert-butylguanidino)methyl)benzamide
-
1 mM, 37°C, pH 7, 39% inhibition
3-(3,3-diisopropylguanidino)benzamide
-
1 mM, 37°C, pH 7, 15% inhibition
3-(3-(1-benzylpiperidin-4-yl)guanidino)benzamide
-
1 mM, 37°C, pH 7, 58% inhibition
3-(3-(4-bromobenzyl)guanidino)benzamide
-
1 mM, 37°C, pH 7, 22% inhibition
3-(3-benzylguanidino)benzamide
-
1 mM, 37°C, pH 7, 10% inhibition
3-(3-phenylguanidino)benzamide
-
1 mM, 37°C, pH 7, 12% inhibition
3-(3-tert-butylguanidino)benzamide
-
1 mM, 37°C, pH 7, 77% inhibition
4-amino-1,8-naphthalimide
-
-
8-fluoro-2-[3-(piperidin-1-yl)propanoyl]-1,3,4,5-tetrahydrobenzo[c][1,6]naphthyridin-6(2H)-one
-
Cytoplasmic extract of pyBHK-cells
-
not fragment A
-
Elastase
-
inactivation follows pseudo-first order kinetic
-
ethyl 4-(3-(3-carbamoylbenzyl)guanidino)piperidine-1-carboxylate
-
1 mM, 37°C, pH 7, 34% inhibition
histamine
-
250 mM, almost complete inhibition
PJ34
-
additional information
-
cellular ADPribosyltransferase is not inhibited by anti-fragment A-antiserum
-
additional information
-
fragment A and toxin A are not inhibited by histamine
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
4
diethylamino(benzylidine-amino)guanidine
-
-
0.02
elongation factor 2
-
-
additional information
NAD+
0.275
NAD+
-
-
additional information
NAD+
double mutant E546A/R551A, relative KD = 1.11 +/-0.03
additional information
NAD+
-
double mutant E546A/R551A, relative KD = 1.11 +/-0.03
additional information
NAD+
double mutant E546D/R551K, relative KD = 2.71 +/-0.74
additional information
NAD+
-
double mutant E546D/R551K, relative KD = 2.71 +/-0.74
additional information
NAD+
double mutant E546R/R551E, relative KD = 1.29 +/-0.49
additional information
NAD+
-
double mutant E546R/R551E, relative KD = 1.29 +/-0.49
additional information
NAD+
mutant D461A, KD = 1.03 +/-0.02 relative to wild-type (c)
additional information
NAD+
-
mutant D461A, KD = 1.03 +/-0.02 relative to wild-type (c)
additional information
NAD+
mutant D463A, KD = 1.18 +/-0.04 relative to wild-type (c)
additional information
NAD+
-
mutant D463A, KD = 1.18 +/-0.04 relative to wild-type (c)
additional information
NAD+
mutant E546A, relative KD = 1.77 +/-0.34
additional information
NAD+
-
mutant E546A, relative KD = 1.77 +/-0.34
additional information
NAD+
mutant E546D, relative KD = 3.83 +/-0.89
additional information
NAD+
-
mutant E546D, relative KD = 3.83 +/-0.89
additional information
NAD+
mutant E546F, relative KD = 1.97 +/-0.11
additional information
NAD+
-
mutant E546F, relative KD = 1.97 +/-0.11
additional information
NAD+
mutant E546H, relative KD = 1.03 +/-0.09
additional information
NAD+
-
mutant E546H, relative KD = 1.03 +/-0.09
additional information
NAD+
mutant E546N, relative KD = 2.14 +/-0.26
additional information
NAD+
-
mutant E546N, relative KD = 2.14 +/-0.26
additional information
NAD+
mutant E546Q, relative KD = 2.31 +/-0.71
additional information
NAD+
-
mutant E546Q, relative KD = 2.31 +/-0.71
additional information
NAD+
mutant E547A, relative KD = 1.97 +/-0.77
additional information
NAD+
-
mutant E547A, relative KD = 1.97 +/-0.77
additional information
NAD+
mutant E548A, relative KD = 2.69 +/-0.11
additional information
NAD+
-
mutant E548A, relative KD = 2.69 +/-0.11
additional information
NAD+
mutant E553A, relative KD = 2.57 +/-0.86
additional information
NAD+
-
mutant E553A, relative KD = 2.57 +/-0.86
additional information
NAD+
mutant G453A, KD = 4.85 +/-1.07 relative to wild-type (c)
additional information
NAD+
-
mutant G453A, KD = 4.85 +/-1.07 relative to wild-type (c)
additional information
NAD+
mutant G454A, KD = 6.25 +/-0.22 relative to wild-type (c)
additional information
NAD+
-
mutant G454A, KD = 6.25 +/-0.22 relative to wild-type (c)
additional information
NAD+
mutant G549A, relative KD = 8.00 +/-0.94
additional information
NAD+
-
mutant G549A, relative KD = 8.00 +/-0.94
additional information
NAD+
mutant G550A, relative KD = 6.60 +/-0.54
additional information
NAD+
-
mutant G550A, relative KD = 6.60 +/-0.54
additional information
NAD+
mutant L462A, KD = 1.86 +/-0.10 relative to wild-type (c)
additional information
NAD+
-
mutant L462A, KD = 1.86 +/-0.10 relative to wild-type (c)
additional information
NAD+
mutant L552A, relative KD = 4.43 +/-0.57
additional information
NAD+
-
mutant L552A, relative KD = 4.43 +/-0.57
additional information
NAD+
mutant Q460A, KD = 4.30 +/-0.43 relative to wild-type (c)
additional information
NAD+
-
mutant Q460A, KD = 4.30 +/-0.43 relative to wild-type (c)
additional information
NAD+
mutant R456A, KD = 3.56 +/-0.53 relative to wild-type (c)
additional information
NAD+
-
mutant R456A, KD = 3.56 +/-0.53 relative to wild-type (c)
additional information
NAD+
mutant R458A, KD = 5.78 +/-0.18 relative to wild-type (c)
additional information
NAD+
-
mutant R458A, KD = 5.78 +/-0.18 relative to wild-type (c)
additional information
NAD+
mutant R458H, KD = 31.02 +/-7.18 relative to wild-type (d)
additional information
NAD+
-
mutant R458H, KD = 31.02 +/-7.18 relative to wild-type (d)
additional information
NAD+
mutant R458K, KD = 3.18 +/-0.23 relative to wild-type (c)
additional information
NAD+
-
mutant R458K, KD = 3.18 +/-0.23 relative to wild-type (c)
additional information
NAD+
mutant R458Q, KD = 0.45 +/-0.06 relative to wild-type (e)
additional information
NAD+
-
mutant R458Q, KD = 0.45 +/-0.06 relative to wild-type (e)
additional information
NAD+
mutant R458W, KD = 11.26 +/-1.16 relative to wild-type (d)
additional information
NAD+
-
mutant R458W, KD = 11.26 +/-1.16 relative to wild-type (d)
additional information
NAD+
mutant R551A, relative KD = 2.69 +/-0.03
additional information
NAD+
-
mutant R551A, relative KD = 2.69 +/-0.03
additional information
NAD+
mutant R551C, relative KD = 5.57 +/-0.91
additional information
NAD+
-
mutant R551C, relative KD = 5.57 +/-0.91
additional information
NAD+
mutant R551E, relative KD = 5.03 +/-0.51
additional information
NAD+
-
mutant R551E, relative KD = 5.03 +/-0.51
additional information
NAD+
mutant R551H, relative KD = 2.29 +/-0.46
additional information
NAD+
-
mutant R551H, relative KD = 2.29 +/-0.46
additional information
NAD+
mutant R551K, relative KD = 1.29 +/-0.03
additional information
NAD+
-
mutant R551K, relative KD = 1.29 +/-0.03
additional information
NAD+
mutant R551Q, relative KD = 2.63 +/-0.39
additional information
NAD+
-
mutant R551Q, relative KD = 2.63 +/-0.39
additional information
NAD+
mutant S459A, KD = 1.59 +/-0.16 relative to wild-type (c)
additional information
NAD+
-
mutant S459A, KD = 1.59 +/-0.16 relative to wild-type (c)
additional information
NAD+
mutant V455A, KD = 3.31 +/-0.24 relative to wild-type (c)
additional information
NAD+
-
mutant V455A, KD = 3.31 +/-0.24 relative to wild-type (c)
additional information
NAD+
wild-type, KD = 35 +/-3 microM, relative KD = 1.00 +/-0.09, estimated according to quenched intrinsic tryptophan fluorescence upon NAD+ binding to the active site
additional information
NAD+
-
wild-type, KD = 35 +/-3 microM, relative KD = 1.00 +/-0.09, estimated according to quenched intrinsic tryptophan fluorescence upon NAD+ binding to the active site
additional information
NAD+
wild-type, KD = 36 +/-8 microM (c), KD = 62 +/-2 microM (d), KD = 74 +/-16 microM, relative KD = 1.00 +/-0.03
additional information
NAD+
-
wild-type, KD = 36 +/-8 microM (c), KD = 62 +/-2 microM (d), KD = 74 +/-16 microM, relative KD = 1.00 +/-0.03
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
12
elongation factor 2
-
-
additional information
NAD+
additional information
NAD+
0.0062-0.13/min, wild-type GH activity, in the absence of eEF2, pH 7.9, 25°C, 60 min
additional information
NAD+
-
0.0062-0.13/min, wild-type GH activity, in the absence of eEF2, pH 7.9, 25°C, 60 min
additional information
NAD+
0.125 +/-0.007/min (a), wild-type GH activity, in the absence of eEF2, pH 7.9, 25°C, 60 min
additional information
NAD+
-
0.125 +/-0.007/min (a), wild-type GH activity, in the absence of eEF2, pH 7.9, 25°C, 60 min
additional information
NAD+
0.130 +/-0.012/min (b), wild-type GH activity, in the absence of eEF2, pH 7.9, 25°C, 60 min
additional information
NAD+
-
0.130 +/-0.012/min (b), wild-type GH activity, in the absence of eEF2, pH 7.9, 25°C, 60 min
additional information
NAD+
1306 +/-121/min (a), wild-type ADPRT activity, 12 microM eEF2, pH 7.9, 25°C, 300 sec
additional information
NAD+
-
1306 +/-121/min (a), wild-type ADPRT activity, 12 microM eEF2, pH 7.9, 25°C, 300 sec
additional information
NAD+
1495 +/-224/min (b), wild-type ADPRT activity, 12 microM eEF2, pH 7.9, 25°C, 300 sec
additional information
NAD+
-
1495 +/-224/min (b), wild-type ADPRT activity, 12 microM eEF2, pH 7.9, 25°C, 300 sec
additional information
NAD+
628 +/-8/min (B), wild-type ADPRT activity, 12 microM eEF2, pH 7.9, 25°C, 300 sec
additional information
NAD+
-
628 +/-8/min (B), wild-type ADPRT activity, 12 microM eEF2, pH 7.9, 25°C, 300 sec
additional information
NAD+
746 +/-18/min (A), wild-type ADPRT activity, 12 microM eEF2, pH 7.9, 25°C, 300 sec
additional information
NAD+
-
746 +/-18/min (A), wild-type ADPRT activity, 12 microM eEF2, pH 7.9, 25°C, 300 sec
additional information
NAD+
847 +/-21/min (C), wild-type ADPRT activity, 12 microM eEF2, pH 7.9, 25°C, 300 sec
additional information
NAD+
-
847 +/-21/min (C), wild-type ADPRT activity, 12 microM eEF2, pH 7.9, 25°C, 300 sec
additional information
NAD+
900 +/-20/min (D), wild-type ADPRT activity, 12 microM eEF2, pH 7.9, 25°C, 300 sec
additional information
NAD+
-
900 +/-20/min (D), wild-type ADPRT activity, 12 microM eEF2, pH 7.9, 25°C, 300 sec
additional information
NAD+
double mutant E546A/R551A, kcat = 0.0001 +/-0.0001, relative to wild-type ADPRT activity (C)
additional information
NAD+
-
double mutant E546A/R551A, kcat = 0.0001 +/-0.0001, relative to wild-type ADPRT activity (C)
additional information
NAD+
double mutant E546A/R551A, kcat = 0.84 +/-0.04, relative to wild-type GH activity
additional information
NAD+
-
double mutant E546A/R551A, kcat = 0.84 +/-0.04, relative to wild-type GH activity
additional information
NAD+
double mutant E546D/R551K, kcat = 0.0009 +/-0.0013, relative to wild-type ADPRT activity (C)
additional information
NAD+
-
double mutant E546D/R551K, kcat = 0.0009 +/-0.0013, relative to wild-type ADPRT activity (C)
additional information
NAD+
double mutant E546D/R551K, kcat = 0.42 +/-0.0002, relative to wild-type GH activity
additional information
NAD+
-
double mutant E546D/R551K, kcat = 0.42 +/-0.0002, relative to wild-type GH activity
additional information
NAD+
double mutant E546R/R551E, kcat = 0.00001 +/-0.000002, relative to wild-type ADPRT activity (C)
additional information
NAD+
-
double mutant E546R/R551E, kcat = 0.00001 +/-0.000002, relative to wild-type ADPRT activity (C)
additional information
NAD+
double mutant E546R/R551E, kcat = 0.38 +/-0.01, relative to wild-type GH activity
additional information
NAD+
-
double mutant E546R/R551E, kcat = 0.38 +/-0.01, relative to wild-type GH activity
additional information
NAD+
mutant D461A, kcat = 1.001 +/-0.091, relative to wild-type ADPRT activity (a)
additional information
NAD+
-
mutant D461A, kcat = 1.001 +/-0.091, relative to wild-type ADPRT activity (a)
additional information
NAD+
mutant D461A, kcat = 1.076 +/-0.041, relative to wild-type GH activity (a)
additional information
NAD+
-
mutant D461A, kcat = 1.076 +/-0.041, relative to wild-type GH activity (a)
additional information
NAD+
mutant D463A, kcat = 1.148 +/-0.038, relative to wild-type GH activity (a)
additional information
NAD+
-
mutant D463A, kcat = 1.148 +/-0.038, relative to wild-type GH activity (a)
additional information
NAD+
mutant D463A, kcat = 1.270 +/-0.204, relative to wild-type ADPRT activity (a)
additional information
NAD+
-
mutant D463A, kcat = 1.270 +/-0.204, relative to wild-type ADPRT activity (a)
additional information
NAD+
mutant E546A, kcat = 0.0012 +/-0.00002, relative to wild-type ADPRT activity (A)
additional information
NAD+
-
mutant E546A, kcat = 0.0012 +/-0.00002, relative to wild-type ADPRT activity (A)
additional information
NAD+
mutant E546A, kcat = 0.24 +/-0.008, relative to wild-type GH activity
additional information
NAD+
-
mutant E546A, kcat = 0.24 +/-0.008, relative to wild-type GH activity
additional information
NAD+
mutant E546D, kcat = 0.00025 +/-0.00005, relative to wild-type ADPRT activity (B)
additional information
NAD+
-
mutant E546D, kcat = 0.00025 +/-0.00005, relative to wild-type ADPRT activity (B)
additional information
NAD+
mutant E546D, kcat = 0.45 +/-0.002, relative to wild-type GH activity
additional information
NAD+
-
mutant E546D, kcat = 0.45 +/-0.002, relative to wild-type GH activity
additional information
NAD+
mutant E546F, kcat = 0.007 +/-0.0002, relative to wild-type ADPRT activity (D)
additional information
NAD+
-
mutant E546F, kcat = 0.007 +/-0.0002, relative to wild-type ADPRT activity (D)
additional information
NAD+
mutant E546F, kcat = 0.69 +/-0.05, relative to wild-type GH activity
additional information
NAD+
-
mutant E546F, kcat = 0.69 +/-0.05, relative to wild-type GH activity
additional information
NAD+
mutant E546H, kcat = 0.0012 +/-0.0002, relative to wild-type ADPRT activity (B)
additional information
NAD+
-
mutant E546H, kcat = 0.0012 +/-0.0002, relative to wild-type ADPRT activity (B)
additional information
NAD+
mutant E546H, kcat = 0.59 +/-0.009, relative to wild-type GH activity
additional information
NAD+
-
mutant E546H, kcat = 0.59 +/-0.009, relative to wild-type GH activity
additional information
NAD+
mutant E546N, kcat = 0.0010 +/-0.00009, relative to wild-type ADPRT activity (B)
additional information
NAD+
-
mutant E546N, kcat = 0.0010 +/-0.00009, relative to wild-type ADPRT activity (B)
additional information
NAD+
mutant E546N, kcat = 0.67 +/-0.03, relative to wild-type GH activity
additional information
NAD+
-
mutant E546N, kcat = 0.67 +/-0.03, relative to wild-type GH activity
additional information
NAD+
mutant E546Q, kcat = 0.011 +/-0.002, relative to wild-type ADPRT activity (B)
additional information
NAD+
-
mutant E546Q, kcat = 0.011 +/-0.002, relative to wild-type ADPRT activity (B)
additional information
NAD+
mutant E546Q, kcat = 0.80 +/-0.04, relative to wild-type GH activity
additional information
NAD+
-
mutant E546Q, kcat = 0.80 +/-0.04, relative to wild-type GH activity
additional information
NAD+
mutant E547A, kcat = 0.795 +/-0.077, relative to wild-type ADPRT activity (A)
additional information
NAD+
-
mutant E547A, kcat = 0.795 +/-0.077, relative to wild-type ADPRT activity (A)
additional information
NAD+
mutant E547A, kcat = 0.83 +/-0.14, relative to wild-type GH activity
additional information
NAD+
-
mutant E547A, kcat = 0.83 +/-0.14, relative to wild-type GH activity
additional information
NAD+
mutant E548A, kcat = 0.76 +/-0.01, relative to wild-type GH activity
additional information
NAD+
-
mutant E548A, kcat = 0.76 +/-0.01, relative to wild-type GH activity
additional information
NAD+
mutant E548A, kcat = 1.669 +/-0.298, relative to wild-type ADPRT activity (A)
additional information
NAD+
-
mutant E548A, kcat = 1.669 +/-0.298, relative to wild-type ADPRT activity (A)
additional information
NAD+
mutant E553A, kcat = 0.0015 +/-0.00005, relative to wild-type ADPRT activity (A)
additional information
NAD+
-
mutant E553A, kcat = 0.0015 +/-0.00005, relative to wild-type ADPRT activity (A)
additional information
NAD+
mutant E553A, kcat = 0.07 +/-0.009, relative to wild-type GH activity
additional information
NAD+
-
mutant E553A, kcat = 0.07 +/-0.009, relative to wild-type GH activity
additional information
NAD+
mutant G453A, kcat = 0.290 +/-0.040, relative to wild-type ADPRT activity (a)
additional information
NAD+
-
mutant G453A, kcat = 0.290 +/-0.040, relative to wild-type ADPRT activity (a)
additional information
NAD+
mutant G453A, kcat = 0.331 +/-0.019, relative to wild-type GH activity (a)
additional information
NAD+
-
mutant G453A, kcat = 0.331 +/-0.019, relative to wild-type GH activity (a)
additional information
NAD+
mutant G454A, kcat = 0.031 +/-0.003, relative to wild-type GH activity (a)
additional information
NAD+
-
mutant G454A, kcat = 0.031 +/-0.003, relative to wild-type GH activity (a)
additional information
NAD+
mutant G454A, kcat = 0.046 +/-0.008, relative to wild-type ADPRT activity (a)
additional information
NAD+
-
mutant G454A, kcat = 0.046 +/-0.008, relative to wild-type ADPRT activity (a)
additional information
NAD+
mutant G549A, kcat = 0.30 +/-0.005, relative to wild-type GH activity
additional information
NAD+
-
mutant G549A, kcat = 0.30 +/-0.005, relative to wild-type GH activity
additional information
NAD+
mutant G549A, kcat = 0.770 +/-0.076, relative to wild-type ADPRT activity (A)
additional information
NAD+
-
mutant G549A, kcat = 0.770 +/-0.076, relative to wild-type ADPRT activity (A)
additional information
NAD+
mutant G550A, kcat = 0.41 +/-0.04, relative to wild-type GH activity
additional information
NAD+
-
mutant G550A, kcat = 0.41 +/-0.04, relative to wild-type GH activity
additional information
NAD+
mutant G550A, kcat = 0.562 +/-0.166, relative to wild-type ADPRT activity (A)
additional information
NAD+
-
mutant G550A, kcat = 0.562 +/-0.166, relative to wild-type ADPRT activity (A)
additional information
NAD+
mutant L462A, kcat = 0.268 +/-0.041, relative to wild-type ADPRT activity (a)
additional information
NAD+
-
mutant L462A, kcat = 0.268 +/-0.041, relative to wild-type ADPRT activity (a)
additional information
NAD+
mutant L462A, kcat = 0.955 +/-0.015, relative to wild-type GH activity (a)
additional information
NAD+
-
mutant L462A, kcat = 0.955 +/-0.015, relative to wild-type GH activity (a)
additional information
NAD+
mutant L552A, kcat = 0.58 +/-0.002, relative to wild-type GH activity
additional information
NAD+
-
mutant L552A, kcat = 0.58 +/-0.002, relative to wild-type GH activity
additional information
NAD+
mutant L552A, kcat = 2.365 +/-0.527, relative to wild-type ADPRT activity (A)
additional information
NAD+
-
mutant L552A, kcat = 2.365 +/-0.527, relative to wild-type ADPRT activity (A)
additional information
NAD+
mutant Q460A, kcat = 0.115 +/-0.010, relative to wild-type ADPRT activity (a)
additional information
NAD+
-
mutant Q460A, kcat = 0.115 +/-0.010, relative to wild-type ADPRT activity (a)
additional information
NAD+
mutant Q460A, kcat = 0.622 +/-0.014, relative to wild-type GH activity (a)
additional information
NAD+
-
mutant Q460A, kcat = 0.622 +/-0.014, relative to wild-type GH activity (a)
additional information
NAD+
mutant R456A, kcat = 0.230 +/-0.010, relative to wild-type GH activity (a)
additional information
NAD+
-
mutant R456A, kcat = 0.230 +/-0.010, relative to wild-type GH activity (a)
additional information
NAD+
mutant R456A, kcat = 0.239 +/-0.034, relative to wild-type ADPRT activity (a)
additional information
NAD+
-
mutant R456A, kcat = 0.239 +/-0.034, relative to wild-type ADPRT activity (a)
additional information
NAD+
mutant R458A, kcat = 0.132 +/-0.031, relative to wild-type ADPRT activity (a)
additional information
NAD+
-
mutant R458A, kcat = 0.132 +/-0.031, relative to wild-type ADPRT activity (a)
additional information
NAD+
mutant R458A, kcat = 0.249 +/-0.021, relative to wild-type GH activity (a)
additional information
NAD+
-
mutant R458A, kcat = 0.249 +/-0.021, relative to wild-type GH activity (a)
additional information
NAD+
mutant R458H, kcat = 0.018 +/-0.003, relative to wild-type GH activity (b)
additional information
NAD+
-
mutant R458H, kcat = 0.018 +/-0.003, relative to wild-type GH activity (b)
additional information
NAD+
mutant R458H, kcat = 0.019 +/-0.007, relative to wild-type ADPRT activity (b)
additional information
NAD+
-
mutant R458H, kcat = 0.019 +/-0.007, relative to wild-type ADPRT activity (b)
additional information
NAD+
mutant R458K, kcat = 0.428 +/-0.033, relative to wild-type GH activity (a)
additional information
NAD+
-
mutant R458K, kcat = 0.428 +/-0.033, relative to wild-type GH activity (a)
additional information
NAD+
mutant R458K, kcat = 0.543 +/-0.155, relative to wild-type ADPRT activity (a)
additional information
NAD+
-
mutant R458K, kcat = 0.543 +/-0.155, relative to wild-type ADPRT activity (a)
additional information
NAD+
mutant R458Q, kcat = 0.650 +/-0.130, relative to wild-type ADPRT activity (b)
additional information
NAD+
-
mutant R458Q, kcat = 0.650 +/-0.130, relative to wild-type ADPRT activity (b)
additional information
NAD+
mutant R458Q, kcat = 0.991 +/-0.017, relative to wild-type GH activity (b)
additional information
NAD+
-
mutant R458Q, kcat = 0.991 +/-0.017, relative to wild-type GH activity (b)
additional information
NAD+
mutant R458W, kcat = 0.379 +/-0.043, relative to wild-type ADPRT activity (b)
additional information
NAD+
-
mutant R458W, kcat = 0.379 +/-0.043, relative to wild-type ADPRT activity (b)
additional information
NAD+
mutant R458W, kcat = 0.438 +/-0.040, relative to wild-type GH activity (b)
additional information
NAD+
-
mutant R458W, kcat = 0.438 +/-0.040, relative to wild-type GH activity (b)
additional information
NAD+
mutant R551A, kcat = 0.32 +/-0.005, relative to wild-type GH activity
additional information
NAD+
-
mutant R551A, kcat = 0.32 +/-0.005, relative to wild-type GH activity
additional information
NAD+
mutant R551A, kcat = 0.380 +/-0.024, relative to wild-type ADPRT activity (A)
additional information
NAD+
-
mutant R551A, kcat = 0.380 +/-0.024, relative to wild-type ADPRT activity (A)
additional information
NAD+
mutant R551C, kcat = ~0, relative to wild-type ADPRT activity (B)
additional information
NAD+
-
mutant R551C, kcat = ~0, relative to wild-type ADPRT activity (B)
additional information
NAD+
mutant R551C, kcat = 0.10 +/-0.006, relative to wild-type GH activity
additional information
NAD+
-
mutant R551C, kcat = 0.10 +/-0.006, relative to wild-type GH activity
additional information
NAD+
mutant R551E, kcat = 0.011 +/-0.005, relative to wild-type ADPRT activity (B)
additional information
NAD+
-
mutant R551E, kcat = 0.011 +/-0.005, relative to wild-type ADPRT activity (B)
additional information
NAD+
mutant R551E, kcat = 0.09 +/-0.001, relative to wild-type GH activity
additional information
NAD+
-
mutant R551E, kcat = 0.09 +/-0.001, relative to wild-type GH activity
additional information
NAD+
mutant R551H, kcat = ~0, relative to wild-type ADPRT activity (B)
additional information
NAD+
-
mutant R551H, kcat = ~0, relative to wild-type ADPRT activity (B)
additional information
NAD+
mutant R551H, kcat = 0.41 +/-0.002, relative to wild-type GH activity
additional information
NAD+
-
mutant R551H, kcat = 0.41 +/-0.002, relative to wild-type GH activity
additional information
NAD+
mutant R551K, kcat = 0.317 +/-0.024, relative to wild-type ADPRT activity (B)
additional information
NAD+
-
mutant R551K, kcat = 0.317 +/-0.024, relative to wild-type ADPRT activity (B)
additional information
NAD+
mutant R551K, kcat = 0.69 +/-0.03, relative to wild-type GH activity
additional information
NAD+
-
mutant R551K, kcat = 0.69 +/-0.03, relative to wild-type GH activity
additional information
NAD+
mutant R551Q, kcat = 0.185 +/-0.014, relative to wild-type ADPRT activity (B)
additional information
NAD+
-
mutant R551Q, kcat = 0.185 +/-0.014, relative to wild-type ADPRT activity (B)
additional information
NAD+
mutant R551Q, kcat = 0.38 +/-0.01, relative to wild-type GH activity
additional information
NAD+
-
mutant R551Q, kcat = 0.38 +/-0.01, relative to wild-type GH activity
additional information
NAD+
mutant S459A, kcat = 1.119 +/-0.054, relative to wild-type GH activity (a)
additional information
NAD+
-
mutant S459A, kcat = 1.119 +/-0.054, relative to wild-type GH activity (a)
additional information
NAD+
mutant S459A, kcat = 1.256 +/-0.144, relative to wild-type ADPRT activity (a)
additional information
NAD+
-
mutant S459A, kcat = 1.256 +/-0.144, relative to wild-type ADPRT activity (a)
additional information
NAD+
mutant V455A, kcat = 0.241 +/-0.032, relative to wild-type ADPRT activity (a)
additional information
NAD+
-
mutant V455A, kcat = 0.241 +/-0.032, relative to wild-type ADPRT activity (a)
additional information
NAD+
mutant V455A, kcat = 0.254 +/-0.001, relative to wild-type GH activity (a)
additional information
NAD+
-
mutant V455A, kcat = 0.254 +/-0.001, relative to wild-type GH activity (a)
additional information
NAD+
relative kcat = 1.00 +/-0.02, wild-type GH activity
additional information
NAD+
-
relative kcat = 1.00 +/-0.02, wild-type GH activity
additional information
NAD+
relative kcat = 1.00 +/-0.05, wild-type GH activity (a) and (b)
additional information
NAD+
-
relative kcat = 1.00 +/-0.05, wild-type GH activity (a) and (b)
additional information
NAD+
relative kcat = 1.00 +/-0.09, wild-type ADPRT activity (A)-(D), and (a) and (b)
additional information
NAD+
-
relative kcat = 1.00 +/-0.09, wild-type ADPRT activity (A)-(D), and (a) and (b)
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Lee, H.; Iglewski, W.J.
Cellular ADP-ribosyltransferase with the same mechanism of action as diphtheria toxin and Pseudomonas toxin A
Proc. Natl. Acad. Sci. USA
81
2703-2707
1984
Bos taurus, Mesocricetus auratus, Pseudomonas aeruginosa
brenda
Sanai, Y.; Morihara, K.; Tsuzuki, H.; Homma, J.Y.; Kato, I.
Proteolytic cleavage of exotoxin A from Pseudomonas aeruginosa: formation of an ADP-ribosyltransferase active fragment by the action of Pseudomonas elastase
FEBS Lett.
120
131-134
1980
Pseudomonas aeruginosa
brenda
Leppla, S.H.; Martin, O.C.; Muehl, L.A.
The exotoxin P. aeruginosa: a proenzyme having an unusual mode of activation
Biochem. Biophys. Res. Commun.
81
532-538
1978
Pseudomonas aeruginosa
brenda
Armstrong, S.; Merrill, A.R.
Toward the elucidation of the catalytic mechanism of the mono-ADP-ribosyltransferase activity of Pseudomonas aeruginosa exotoxin A
Biochemistry
43
183-194
2004
Pseudomonas aeruginosa
brenda
Zhang, Y.; Liu, S.; Lajoie, G.; Merrill, A.R.
The role of the diphthamide-containing loop within eukaryotic elongation factor 2 in ADP-ribosylation by Pseudomonas aeruginosa exotoxin A
Biochem. J.
413
163-174
2008
Pseudomonas aeruginosa
brenda
Jorgensen, R.; Wang, Y.; Visschedyk, D.; Merrill, A.R.
The nature and character of the transition state for the ADP-ribosyltransferase reaction
EMBO Rep.
9
802-809
2008
Pseudomonas aeruginosa (P11439), Pseudomonas aeruginosa
brenda
Zhang, G.
Design, synthesis, and evaluation of bisubstrate analog inhibitors of cholera toxin
Bioorg. Med. Chem. Lett.
18
3724-3727
2008
Vibrio cholerae serotype O1
brenda
Feng, B.S.; Zheng, P.Y.; Chen, X.; Liao, X.Q.; Yang, P.C.
Investigation of the role of cholera toxin in assisting the initiation of the antigen-specific Th2 response
Immunol. Invest.
37
782-797
2008
Vibrio cholerae serotype O1
brenda
Jang, H.; Kim, H.S.; Kim, J.A.; Seo, J.H.; Carbis, R.
Improved purification process for cholera toxin and its application to the quantification of residual toxin in cholera vaccines
J. Microbiol. Biotechnol.
19
108-112
2009
Vibrio cholerae serotype O1, Vibrio cholerae serotype O1 569B
brenda
Gong, Z.; Long, X.; Pan, L.; Le, Y.; Liu, Q.; Wang, S.; Guo, J.; Xiao, B.; Zhou, M.; Mei, D.
Cloning, expression, purification and characterization of the cholera toxin B subunit and triple glutamic acid decarboxylase epitopes fusion protein in Escherichia coli
Protein Expr. Purif.
191
191-197
2009
Vibrio cholerae serotype O1
brenda
Fieldhouse, R.J.; Jurgensen, R.; Lugo, M.R.; Merrill, A.R.
The 1.8 A cholix toxin crystal structure in complex with NAD+ and evidence for a new kinetic model
J. Biol. Chem.
287
21176-21188
2012
Vibrio cholerae serotype O1
brenda
Lugo, M.R.; Merrill, A.R.
The father, son and cholix toxin: The third member of the dt group mono-ADP-ribosyltransferase toxin family
Toxins
7
2757-2772
2015
Pseudomonas aeruginosa (P11439), Pseudomonas aeruginosa, Vibrio cholerae (Q5EK40), Vibrio cholerae
brenda
Avila, E.E.; Rodriguez, O.I.; Marquez, J.A.; Berghuis, A.M.
An Entamoeba histolytica ADP-ribosyl transferase from the diphtheria toxin family modifies the bacterial elongation factor Tu
Mol. Biochem. Parasitol.
207
68-74
2016
Entamoeba histolytica (C4LWB1), Entamoeba histolytica
brenda
Masuyer, G.
Crystal structure of exotoxin A from Aeromonas pathogenic species
Toxins
12
397
2020
Aeromonas hydrophila
brenda